GO:0018872 arsonoacetate metabolic process

Arsonoacetate metabolic process (GO:0018872) is a biological process defined as the chemical reactions and pathways involving arsonoacetate, a synthetic organic compound containing a single arsenic atom. Arsonoacetate and other arsenic-containing compounds are used in agricultural applications as animal feed additives, cotton defoliants and post-emergence grass herbicides. The study of this process is important because it addresses how living organisms, particularly bacteria, can transform or degrade organoarsenical compounds, which has implications for environmental toxicology and bioremediation. The carbon-arsenic bond is a key target in this metabolism, and its cleavage has been experimentally demonstrated in a gram-negative bacterium, strain ASV2. Understanding arsonoacetate metabolism also connects to broader research on arsenic biogeochemistry and the fate of anthropogenic arsenic compounds in the environment. Additionally, arsonoacetate has been investigated as a tracer compound in nuclear medicine, where double tracer studies with 76As and 99mTc labeled arsonomethylphosphonate and arsonoacetate were performed. This highlights the potential utility of arsonoacetate derivatives in biomedical imaging, although the metabolic fate of these compounds remains an active area of research. The process is also relevant to the study of phosphonate and phosphonoacetate metabolism, as similar enzymatic strategies may be involved in carbon-phosphorus bond cleavage. Phosphonoformate, a related compound, has been studied for its antiviral mode of action, providing a comparative framework for understanding organoarsenical and organophosphorus metabolism. Overall, GO:0018872 represents a specialized metabolic pathway with significance for microbiology, environmental science, and drug development [1, 3, 4, 5].

According to the Gene Ontology, arsonoacetate metabolic process (GO:0018872) is defined as the chemical reactions and pathways involving arsonoacetate, a synthetic, organic compound containing a single arsenic atom. The definition notes that arsonoacetate and other arsenic-containing compounds are used in agricultural applications as animal feed additives, cotton defoliants and post-emergence grass herbicides. This process encompasses the enzymatic or non-enzymatic transformations of arsonoacetate, including potential carbon-arsenic bond cleavage, which has been observed in a gram-negative bacterial strain. The term is a biological process and is synonymous with arsonoacetate metabolism.

Arsonoacetate metabolic process is important because it governs the fate of a synthetic organoarsenical compound that has been widely used in agriculture, and its breakdown determines the environmental persistence and toxicity of arsenic-containing herbicides and feed additives. The ability of microorganisms to cleave the carbon-arsenic bond, as shown in strain ASV2, is a critical step in bioremediation and in understanding the global arsenic cycle. Furthermore, arsonoacetate and its derivatives have been explored as radiotracers, linking this metabolic process to nuclear medicine and imaging research. Studies on related compounds such as phosphonoformate and phosphonoacetate provide additional context for the enzymatic mechanisms that may be shared or distinct [3, 4].

The following genes and proteins have been associated with arsonoacetate metabolic process or related organoarsenical and phosphonate metabolism in the verified literature.

The regulation of arsonoacetate metabolic process is not well characterized in the available literature. However, by analogy with related phosphonate metabolism, the LysR-like transcriptional regulator PhnR from Pseudomonas fluorescens 23F controls the expression of genes involved in phosphonoacetate utilization, and a whole-cell biosensor for phosphonoacetate was constructed based on PhnR. This suggests that similar regulatory mechanisms may exist for arsonoacetate metabolism, but direct evidence is lacking. Additionally, the mode of action of phosphonoformate as an anti-herpes simplex virus agent involves inhibition of viral DNA polymerase, indicating that organophosphorus compounds can interact with nucleic acid metabolism. Further research is needed to identify specific regulatory proteins for arsonoacetate metabolic process [1, 4].

Arsonoacetate is an organoarsenical compound, and its metabolism is directly relevant to arsenic toxicity. Arsenic exposure is associated with various health effects, including cancer and skin lesions, although the specific role of arsonoacetate metabolism in human disease has not been established in the provided literature. The microbial cleavage of the carbon-arsenic bond may influence the bioavailability of arsenic in the environment, thereby affecting human exposure through contaminated water or food.

Global metabolomic profiling of human synovial fluid has been used to identify biomarkers for rheumatoid arthritis. While this study does not directly investigate arsonoacetate metabolism, it exemplifies the application of metabolomic approaches to disease biomarker discovery. Such methodologies could potentially be applied to study the metabolic fate of organoarsenicals in human biofluids, but this remains speculative.

Phosphonoformate, a compound related to arsonoacetate in that it contains a phosphorus-carbon bond, acts as an anti-herpes simplex virus agent by inhibiting viral DNA polymerase. This highlights how organophosphorus compounds can target nucleic acid metabolism, providing a conceptual link to organoarsenical metabolism. However, no direct evidence links arsonoacetate metabolism to antiviral activity.

Double tracer studies with 76As and 99mTc labeled arsonomethylphosphonate and arsonoacetate have been conducted, indicating potential applications in nuclear medicine imaging. These studies suggest that arsonoacetate derivatives can be used as radiotracers, but their metabolic processing in vivo and any associated disease relevance require further investigation.

Global metabolomic profiling of biological samples, such as synovial fluid, can identify metabolites and biomarkers associated with disease. This approach could be adapted to detect arsonoacetate and its degradation products in environmental or clinical samples, although specific studies are lacking.

Double tracer studies using 76As and 99mTc labeled arsonomethylphosphonate and arsonoacetate allow researchers to track the distribution and metabolism of these compounds in vivo. Such methods are valuable for understanding the pharmacokinetics and potential imaging applications of arsonoacetate derivatives.

A whole-cell biosensor for phosphonoacetate was constructed based on the LysR-like transcriptional regulator PhnR from Pseudomonas fluorescens 23F. This biosensor technology can be adapted to detect arsonoacetate or its metabolites, providing a sensitive and specific tool for environmental monitoring.

The isolation of gram-negative bacterium strain ASV2, which cleaves the carbon-arsenic bond in arsonoacetate, demonstrates the value of classical microbiological methods for discovering novel metabolic activities. Enrichment cultures and selective media can be used to isolate additional arsonoacetate-degrading microorganisms.

Researchers studying arsonoacetate metabolic process-related genes often need to determine whether a candidate gene is causally involved in carbon-arsenic bond cleavage, arsenic resistance, or related metabolic pathways. EDITGENE provides comprehensive CRISPR gene editing services to enable precise functional studies in microbial and mammalian models.

Arsonoacetate metabolic process (GO:0018872) is a specialized biological process centered on the transformation of a synthetic organoarsenical compound used in agriculture. The carbon-arsenic bond cleavage demonstrated in strain ASV2 highlights the microbial capacity to degrade such compounds, with implications for bioremediation and environmental health. Related research on phosphonoacetate biosensors and phosphonoformate antiviral activity provides comparative insights into organoheteroatom metabolism [3, 4]. Radiolabeled arsonoacetate studies further suggest potential biomedical applications. Continued investigation using CRISPR and other molecular tools will elucidate the genes and mechanisms underlying this process, offering opportunities for biotechnological and therapeutic development [1, 4].